Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
95
datasets available to search
ShareScore release 0.9.0
Dataset results
95 results for “viral suppression”
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
ClinicalTrials.gov study NCT05384145. IPD Sharing: NO. Countries: 1. Publications: 0.
Impact of MK-0518 (Raltegravir) Intensification on HIV-1 Viral Latency in Patients With Previous Complete Viral Suppression
ClinicalTrials.gov study NCT00554398. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Improvement of Portal Hypertension During Viral Suppression in Patients With Hepatitis Delta (IMPHROVE-D)
ClinicalTrials.gov study NCT04863703. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders
ClinicalTrials.gov study NCT00704106. IPD Sharing: Not stated. Countries: 1. Publications: 15.
Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)
ClinicalTrials.gov study NCT00371592. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy in HIV Patients With Viral Suppression
ClinicalTrials.gov study NCT01471821. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Multidisciplinary Low-Barrier and Mobile HIV Care to Improve Retention and Viral Suppression: Stakeholder-Engaged Design and Evaluation
ClinicalTrials.gov study NCT05887557. IPD Sharing: YES. Countries: 1. Publications: 1.
Quantitative Measurement and Correlates of the Latent HIV Reservoir in Virally Suppressed Ugandans
ClinicalTrials.gov study NCT02154035. IPD Sharing: NO. Countries: 1. Publications: 2.
Latent HIV-1, Viral Suppress and Hope for HIV Cure
ClinicalTrials.gov study NCT04938518. IPD Sharing: NO. Countries: 1. Publications: 19.
Engaging Men Through HIV Self-Testing With Differentiated Care to Improve ART Initiation and Viral Suppression Among Men in Malawi
ClinicalTrials.gov study NCT04858243. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Impact of Raltegravir Intensification on HIV-1-infected Subjects With Complete Viral Suppression Under Monotherapy With Protease Inhibitors
ClinicalTrials.gov study NCT01480713. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Intermittent Therapy in HIV-1 Infected Patients With Successful Viral Suppression Under Highly Active Antiretroviral Therapy (HAART)
ClinicalTrials.gov study NCT00122551. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Switching From TDF-based Antiretroviral Therapy Regimens to B/F/TAF in Virally Suppressed Adults With HIV-1 Infection
ClinicalTrials.gov study NCT05122754. IPD Sharing: NO. Countries: 1. Publications: 1.
Short Adherence Intervention for Viral Re-suppression
ClinicalTrials.gov study NCT03242980. IPD Sharing: NO. Countries: 1. Publications: 3.
Gabapentin to Reduce Alcohol and Improve Viral Load Suppression
ClinicalTrials.gov study NCT05443555. IPD Sharing: NO. Countries: 1. Publications: 1.
Dose Escalation Study to Determine the Pharmacokinetics of Atazanavir Administered With RIfampicin to HIV Positive Adults on sEcond-line ART Regimen With Suppressed HIV-1 Viral Load
ClinicalTrials.gov study NCT04121195. IPD Sharing: YES. Countries: 1. Publications: 2.
Data from: Optimizing prevention of HIV mother to child transmission: duration of antiretroviral therapy and viral suppression at delivery among pregnant Malawian women
Open the record for dataset details and reuse information.
Viral suppression after transition from nonnucleoside reverse transcriptase inhibitor- to dolutegravir-based antiretroviral therapy: A prospective cohort study in Lesotho (DO-REAL study)
<p>Pseudonymized dataset for the published manuscript "Viral suppression after transition from nonnucleoside reverse transcriptase inhibitor- to dolutegravir-based antiretroviral therapy: A prospective cohort study in Lesotho (DO-REAL study)"</p>
Pilot Study of Effect of Kaletra on CD4 Response in HIV Positive (+) Patients With Viral Suppression KIMBO Study
ClinicalTrials.gov study NCT00344487. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of PRO 140 SC As Single Agent Maintenance Therapy in Virally Suppressed Subjects with CCR5-tropic HIV-1 Infection
ClinicalTrials.gov study NCT02859961. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.